Scientific Opinion on the substantiation of health claims related to hydroxypropyl methylcellulose (HPMC) and maintenance of normal bowel function (ID 812), reduction of post-prandial glycaemic responses (ID 814), maintenance of normal blood cholesterol concentrations (ID 815) and increase in satiety leading to a reduction in energy intake (ID 2933) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Tabs

Article
Hydroxypropyl methylcellulose (HPMC), bowel function, post-prandial glycaemic responses, blood cholesterol, satiety, energy intake, health claims.
First published in the EFSA Journal
19 October 2010
Adopted
9 July 2010
Last Updated
9 December 2010. This version replaces the previous one/s.
Type
Opinion of the Scientific Committee/Scientific Panel
Abstract

No abstract available

Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
Panel on Dietetic Products, Nutrition and Allergies
Contact
doi
10.2903/j.efsa.2010.1739
EFSA Journal 2010;8(10):1739 [23 pp.].
On request from
European Commission
Print on demand
Number of Pages
23